First person – Sarah O'Keefe

First Person is a series of interviews with the first authors of a selection of papers published in Journal of Cell Science, helping early-career researchers promote themselves alongside their papers. Sarah O'Keefe is first author on ‘Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor’, published in JCS. Sarah is a postdoc in the lab of Stephen High at the School of Biological Sciences, University of Manchester, UK, where she is developing small molecule inhibitors for the benefit of human health.